Reports of Radiotherapy and Oncology

Published by: Kowsar

First Study of the Safety and Tolerability of Allvec-1, a Gene Therapy Vector, in Patients With Advanced Stage IV Malignant Solid Tumors

Dariush Moslemi 1 , Farzad Jalali 2 , * and Arman Farjam 3
Authors Information
1 Department of Radiation Oncology, Babol University of Medical Sciences, Babol, IR Iran
2 Department of Cardiology, Babol University of Medical Sciences, Babol, IR Iran
3 Department of Pharmacology, Babol University of Medical Sciences, Babol, IR Iran
Article information
  • Reports of Radiotherapy and Oncology: January 28, 2015, 2 (1); e798
  • Published Online: January 24, 2015
  • Article Type: Research Article
  • Received: June 29, 2014
  • Revised: August 12, 2014
  • Accepted: August 16, 2014
  • DOI: 10.5812/rro.2(1)2015.798

To Cite: Moslemi D, Jalali F, Farjam A. First Study of the Safety and Tolerability of Allvec-1, a Gene Therapy Vector, in Patients With Advanced Stage IV Malignant Solid Tumors, Rep Radiother Oncol. 2015 ; 2(1):e798. doi: 10.5812/rro.2(1)2015.798.

Abstract
Copyright © 2015, Iranian Society of Clinical Oncology.This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
References
  • 1. Bleiziffer O, Eriksson E, Yao F, Horch RE, Kneser U. Gene transfer strategies in tissue engineering. J Cell Mol Med. 2007; 11(2): 206-23[PubMed]
  • 2. Gao X, Kim KS, Liu D. Nonviral gene delivery: what we know and what is next. AAPS J. 2007; 9(1)
  • 3. Waehler R, Russell SJ, Curiel DT. Engineering targeted viral vectors for gene therapy. Nat Rev Genet. 2007; 8(8): 573-87
  • 4. Li C, Bowles DE, van Dyke T, Samulski RJ. Adeno-associated virus vectors: potential applications for cancer gene therapy. Cancer Gene Ther. 2005; 12(12): 913-25[DOI][PubMed]
  • 5. Choi VW, McCarty DM, Samulski RJ. AAV hybrid serotypes: improved vectors for gene delivery. Curr Gene Ther. 2005; 5(3): 299-310[PubMed]
  • 6. Montier T, Benvegnu T, Jaffres PA, Yaouanc JJ, Lehn P. Progress in cationic lipid-mediated gene transfection: a series of bio-inspired lipids as an example. Curr Gene Ther. 2008; 8(5): 296-312[PubMed]
  • 7. Collins SA, Guinn BA, Harrison PT, Scallan MF, O'Sullivan GC, Tangney M. Viral vectors in cancer immunotherapy: which vector for which strategy? Curr Gene Ther. 2008; 8(2): 66-78[PubMed]
  • 8. Luten J, van Nostrum CF, De Smedt SC, Hennink WE. Biodegradable polymers as non-viral carriers for plasmid DNA delivery. J Control Release. 2008; 126(2): 97-110[DOI][PubMed]
  • 9. Nishikawa M, Takakura Y, Hashida M. Pharmacokinetic considerations regarding non-viral cancer gene therapy. Cancer Sci. 2008; 99(5): 856-62[PubMed]
  • 10. Agarwal A, Mallapragada SK. Synthetic sustained gene delivery systems. Curr Top Med Chem. 2008; 8(4): 311[PubMed]
  • 11. Sarkis C, Serguera C, Petres S, Buchet D, Ridet JL, Edelman L, et al. Efficient transduction of neural cells in vitro and in vivo by a baculovirus-derived vector. Proc Natl Acad Sci U S A. 2000; 97(26): 14638-43[DOI][PubMed]
  • 12. Pieroni L, La Monica N. Towards the use of baculovirus as a gene therapy vector. Curr Opin Mol Ther. 2001; 3(5): 464-7[PubMed]
  • 13. Condreay JP, Witherspoon SM, Clay WC, Kost TA. Transient and stable gene expression in mammalian cells transduced with a recombinant baculovirus vector. Proc Natl Acad Sci U S A. 1999; 96(1): 127-32[PubMed]
  • 14. Kim YK, Choi JY, Jiang HL, Arote R, Jere D, Cho MH, et al. Hybrid of baculovirus and galactosylated PEI for efficient gene carrier. Virology. 2009; 387(1): 89-97[DOI][PubMed]
  • 15. Kassner PD, Burg MA, Baird A, Larocca D. Genetic selection of phage engineered for receptor-mediated gene transfer to mammalian cells. Biochem Biophys Res Commun. 1999; 264(3): 921-8[DOI][PubMed]
  • 16. Larocca D, Burg MA, Jensen-Pergakes K, Ravey EP, Gonzalez AM, Baird A. Evolving phage vectors for cell targeted gene delivery. Curr Pharm Biotechnol. 2002; 3(1): 45-57[PubMed]
  • 17. Lankes HA, Zanghi CN, Santos K, Capella C, Duke CM, Dewhurst S. In vivo gene delivery and expression by bacteriophage lambda vectors. J Appl Microbiol. 2007; 102(5): 1337-49[PubMed]
  • 18. Eguchi A, Akuta T, Okuyama H, Senda T, Yokoi H, Inokuchi H, et al. Protein transduction domain of HIV-1 Tat protein promotes efficient delivery of DNA into mammalian cells. J Biol Chem. 2001; 276(28): 26204-10[DOI][PubMed]
  • 19. Matsuzaki S, Rashel M, Uchiyama J, Sakurai S, Ujihara T, Kuroda M, et al. Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases. J Infect Chemother. 2005; 11(5): 211-9[DOI][PubMed]
  • 20. Summers WC. Bacteriophage therapy. Annu Rev Microbiol. 2001; 55: 437-51[DOI][PubMed]
  • 21. Raper SE, Chirmule N, Lee FS, Wivel NA, Bagg A, Gao GP, et al. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab. 2003; 80(1-2): 148-58[PubMed]
  • 22. Hacein-Bey-Abina S, von Kalle C, Schmidt M, Le Deist F, Wulffraat N, McIntyre E, et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med. 2003; 348(3): 255-6[DOI][PubMed]
  • 23. Evans CH, Ghivizzani SC, Robbins PD. Arthritis gene therapy's first death. Arthritis Res Ther. 2008; 10(3): 110[DOI][PubMed]
  • 24. Colombo MP, Modesti A, Parmiani G, Forni G. Local cytokine availability elicits tumor rejection and systemic immunity through granulocyte-T-lymphocyte cross-talk. Cancer Res. 1992; 52(18): 4853-7[PubMed]
  • 25. Melcher A, Todryk S, Hardwick N, Ford M, Jacobson M, Vile RG. Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression. Nat Med. 1998; 4(5): 581-7[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments